Most recent update: Tuesday, December 11, 2018 - 11:57

Bariatric News - Cookies & privacy policy

You are here

Obesity paradox

No evidence of obesity paradox for overweight type 2 diabetics

The lowest risk of death was observed among people of normal weight

Being overweight or obese does not lead to improved survival among patients with type 2 diabetes, according to a large-scale study by Harvard School of Public Health (HSPH). The researchers refute previous studies that have suggested that, for people with diabetes being overweight or obese could lead to lower mortality for people compared with normal-weight persons, the so-called ‘obesity paradox’.

"These data dispel the notion that being overweight or obese confers survival advantage among diabetic patients," said Dr Frank Hu, professor of nutrition and epidemiology at HSPH and senior author of the study. "Clearly, weight management is an important therapeutic strategy for overweight or obese individuals with type 2 diabetes."

The study, which is published in the New England Journal of Medicine, analysed data from 8,970 women in the Brigham and Women's Hospital-based Nurses' Health Study (NHS) and 2,457 men in the Health Professionals Follow-up Study (HPFS) with type 2 diabetes.

They calculated participants' BMI shortly before the diagnosis of diabetes and excluded participants reporting a history of diabetes at baseline or cardiovascular disease or cancer before they were diagnosed with diabetes; underweight participants were also excluded.

Outcomes

Participants were followed for a maximum of 36 years (NHS) and 26 years (HPFS). A total of 3,083 deaths were recorded during a mean period of 15.8 years of follow-up. The results showed a positive association between BMI at the time of diabetes diagnosis and risk of death from all causes.

The lowest risk of death was observed among people of normal weight and a lower mortality was not observed among overweight or obese participants. Therefore, the study reported no benefit from being overweight or obese.

In addition, there was a dose-response relationship between BMI and mortality among people who had never smoked, such that a higher BMI just prior to diabetes diagnosis was associated with a higher risk of death. This trend was less pronounced among smokers because smokers tend to be leaner than non-smokers but they have increased risk of death.

The results contradict some previous studies that had shown a benefit-lower risk of death-for patients with chronic illnesses, such as T2DM and excess adiposity.

“We found no evidence of lower mortality among patients with diabetes who were overweight or obese at diagnosis, as compared with their normal-weight counterparts, or of an obesity paradox,” the authors concluded.

The authors cite several limitations in those studies, including small sample sizes, measurement of BMI years after diabetes diagnosis, and failure to properly assess biases from smoking and undiagnosed chronic diseases, which often lead to weight loss.

"In most studies of BMI and mortality, 'normal weight' reference groups are comprised of not only those who are lean and healthy, but also smokers as well as people with existing or undiagnosed illnesses,” said Deirdre Tobias, lead author of the paper and a research fellow in the Department of Nutrition at HSPH. “This can skew the relationship between weight and mortality to make the normal weight group seem worse off than the overweight and obese groups. As a result, people with higher BMIs might have artificially improved survival rates.”

"After carefully controlling for many of these factors in our analysis, we observed that excess weight in those with diabetes was not advantageous for survival. These findings underscore the importance of addressing methodological biases in the analysis of BMI and mortality,” she added.

The study was funded by the National Institutes of Health and the American Diabetes Association.

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.